Artificial Heart-Lung Machine Market Analysis and Outlook Report
Artificial heart-lung machine, commonly known as cardiopulmonary bypass pump, is used to take the role of the heart and lungs during any cardiovascular surgical procedure. While surgeons are performing surgeries, it is very difficult to operate with a beating heart. Therefore, a heart-lung machine is attached to the veins, which permits blood to bypass the heart during any cardiac surgery. The machine pulls the blood from the patient’s body just before reaching the heart, adds oxygen to the blood, and pumps the oxygenated blood to the patient’s body. A special tubing is attached to the larger blood vessel, which draws the oxygen depleted blood from the body. A second set of tubing is attached to the patient’s body to push the oxygenated blood throughout the body. An artificial heart-lung machine is predominantly used in heart transplants and complicated lung surgeries.
The global artificial heart-lung machine market is primarily driven by an increase in the number of cardiac surgeries (particularly open heart surgeries), rising cases of heart transplants, increasing incidence of complicated lung surgeries, high rate of diagnosis and treatment of cardiovascular disease, and development in health care infrastructure. Conversely, the growth of the global heart-lung machine market can be hampered by the high cost of the machine and risks of cardiopulmonary bypass (blood clots, acute kidney injury, improper heart lung function, etc.) in the near future. Nevertheless, mergers and acquisitions of key players, increasing R&D investment by key players, and technological advancements are likely to provide attractive opportunities to the global artificial heart-lung machine market during the forecast period.
Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57270
The global artificial heart-lung machine market can be segmented based on product, application, and end user. In terms of product, the global artificial heart-lung machine market can be segmented into single roller pump and double roller pump. Based on application, the global artificial heart-lung machine market can be classified into cardiac surgeries, lung surgeries, respiratory failure treatment, and others. Based on end user, the global artificial heart-lung machine market can be categorized into hospitals and ambulatory surgeries, clinics, and others.
In terms of region, the global artificial heart-lung machine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. More than 2,500 heart transplants were performed in the U.S. in 2017, a rise of almost 3% in the previous four years. Around 2,000 lung transplants were conducted in the U.S. in the same year, an increase of almost 2% in the previous four years. In around 20 cases, both heart and lung transplants were performed in the U.S. in 2017. The artificial heart-lung machine market in North America accounted for a significant market in 2017, due to a rise in the number of heart transplants, lung transplants, and cardiac surgeries and strong health care infrastructure. Europe held a key share of the artificial heart-lung machine market in 2017, owing to an increase in cardiac surgeries, rise in the number of transplantation cases, presence of prominent market players, and robust health care infrastructure. Increase in population, rise in the incidence of cardiovascular diseases, development in health care infrastructure, and presence of prominent market players (as well as domestic companies) are likely to propel the artificial heart-lung machine market in Asia Pacific during the forecast period. However, weak health care infrastructure, high cost of artificial heart-lung machines, and lack of skilled medical professionals are likely to restrain the artificial heart-lung machine market in Latin America and Middle East & Africa.
Request for Analysis of COVID19 Impact on Artificial Heart-Lung Machine Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=57270
Key companies operating in the global artificial heart-lung machine market are Medtronic, MAQUET Holding B.V. & Co. KG, LivaNova PLC (combined company of Sorin and Cyberonics), Edwards Lifesciences Corporation, TERUMO CORPORATION, and BD.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
Purchase Artificial Heart-Lung Machine Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=57270<ype=S
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Transparency Market Research
90 State Street,
Albany NY – 12207
USA – Canada Toll Free: 866-552-3453